Souza C, Lopes V, Barcellos G, Alexandrino-Junior F, Neves P, Patricio B
J Fungi (Basel). 2024; 10(5).
PMID: 38786699
PMC: 11122123.
DOI: 10.3390/jof10050344.
Heidari A, Sharma R, Shakir Q, Shah M, Clement J, Donnelley M
Clin Infect Dis. 2023; 76(12):2196-2199.
PMID: 36905151
PMC: 10893960.
DOI: 10.1093/cid/ciad146.
Huang J, Cano E, Shweta F, Shah A, Schuetz A, Bois M
Open Forum Infect Dis. 2021; 8(6):ofab266.
PMID: 34159219
PMC: 8214011.
DOI: 10.1093/ofid/ofab266.
Johnson R, Sharma R, Kuran R, Fong I, Heidari A
J Investig Med. 2021; 69(2):316-323.
PMID: 33495302
PMC: 7848065.
DOI: 10.1136/jim-2020-001655.
Jackson N, Blair J, Ampel N
J Fungi (Basel). 2019; 5(3).
PMID: 31261704
PMC: 6787616.
DOI: 10.3390/jof5030054.
Patient With a 42-Year History of Coccidioidal Meningitis.
DAssumpcao C, Heidari A, Johnson R
J Investig Med High Impact Case Rep. 2019; 6:2324709618820047.
PMID: 30622991
PMC: 6302271.
DOI: 10.1177/2324709618820047.
The toxic effects of amphotericin B in man.
HOLEMAN Jr C, Einstein H
Calif Med. 1963; 99:90-3.
PMID: 13961286
PMC: 1515233.
Human coccidioidomycosis.
Smith C, Pappagianis D, LEVINE H, Saito M
Bacteriol Rev. 1961; 25:310-20.
PMID: 13914166
PMC: 441109.
DOI: 10.1128/br.25.3.310-320.1961.
Neurological manifestations after amphotericin B therapy.
HABER R, Joseph M
Br Med J. 1962; 1(5273):230-1.
PMID: 13903385
PMC: 1957276.
DOI: 10.1136/bmj.1.5273.230.
Coccidioidal meningitis. The use of amphotericin B in treatment.
Einstein H, HOLEMAN Jr C, SANDIDGE L, HOLDEN D
Calif Med. 1961; 94:339-43.
PMID: 13726152
PMC: 1574376.
Coccidioidomycosis: evaluation of parameters used to predict outcome with amphotericin B therapy.
Hardenbrook M, Barriere S
Mycopathologia. 1982; 78(2):65-71.
PMID: 7099244
DOI: 10.1007/BF00442628.
Amphotericin B in the treatment of coccidioidomycosis.
Drutz D
Drugs. 1983; 26(4):337-46.
PMID: 6628269
DOI: 10.2165/00003495-198326040-00003.
Disseminated histoplasmosis and its treatment.
PARTRIDGE B, Tanser A
Postgrad Med J. 1966; 42(491):568-72.
PMID: 5950649
PMC: 2465951.
DOI: 10.1136/pgmj.42.491.568.
Amphotericin B serum concentrations during therapy.
Fields Jr B, Bates J, Abernathy R
Appl Microbiol. 1970; 19(6):955-9.
PMID: 5456013
PMC: 376832.
DOI: 10.1128/am.19.6.955-959.1970.
Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis.
Cloninger P, Thrupp L, GRANGER G, Novey H
West J Med. 1974; 120(4):322-5.
PMID: 4821712
PMC: 1129449.
Coccidioidal meningitis. Intrathecal treatment with hyperbaric amphotericin B.
Glynn K, Alazraki N, Waltz T
Calif Med. 1973; 119(3):6-9.
PMID: 4741059
PMC: 1455244.
Cisternal puncture complications. Treatment of coccidioidal meningitis with amphotericin B.
KEANE J
Calif Med. 1973; 119(3):10-5.
PMID: 4741057
PMC: 1455213.
Comparative toxicities of amphotericin B and its monomethyl ester derivative on glial cells in culture.
Racis S, PLESCIA O, Geller H, SCHAFFNER C
Antimicrob Agents Chemother. 1990; 34(7):1360-5.
PMID: 2386367
PMC: 175981.
DOI: 10.1128/AAC.34.7.1360.
Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B.
Collins M, Pappagianis D
Antimicrob Agents Chemother. 1977; 11(6):1049-55.
PMID: 879751
PMC: 352127.
DOI: 10.1128/AAC.11.6.1049.
